Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$13.54 USD
-0.12 (-0.88%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $13.42 -0.12 (-0.89%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth F Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CCRN 13.54 -0.12(-0.88%)
Will CCRN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CCRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CCRN
New Strong Sell Stocks for August 20th
Cross Country Healthcare (CCRN) Reports Q2 Loss, Misses Revenue Estimates
CCRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Kforce (KFRC) Lags Q2 Earnings Estimates
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
Cross Country Healthcare (CCRN) Q1 Earnings Top Estimates
Other News for CCRN
Technical picture remains unchanged for CCRN after it rises 4.12% on September 18
The technical outlook for CCRN is unchanged after it rises 1.86% on September 17
Cross Country Healthcare (CCRN) Shares Rise Amid FTC Speculation
Cross Country Healthcare gains on speculation it wasn't subject of FTC meeting
The technical outlook for CCRN is unchanged after it falls 2.13% on September 16